Clinical TrialsSearch results
Number of results: 66374
Completed
- A Phase 3 study of Efgartigimod PH20 SC in patient with Generalized Myasthenia Gravis
- Generalized Myasthenia Gravis (gMG)
- Matsuura Yuji
- 2021-07-01
Completed
- A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Parsaclisib Plus Investigator's Choice of Either Rituximab or Obinutuzumab in Participants With Relapsed or Refractory Follicular Lymphoma and Marginal Zone Lymphoma
- Follicular Lymphoma (FL) , Marginal Zone Lymphoma (MZL)
- Ueda Eiji
- 2021-09-05
Completed
- A Phase 3, Randomized, Active-Comparator, Observer-Blind, Non-Inferiority Study of DS-5670a in Adults Aged 18 Years and Older
- Prevention of infectious disease by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
- Inoguchi Akihiro
- 2022-08-10
Completed
- A Phase 3, Randomized, Multicenter, Open-label, Active-comparator Controlled Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Machaidze Zurab
- 2022-03-04
Completed
- A Phase 3, Randomized, Open-Label, Controlled, Multicenter Study of Zandelisib (ME-401) in Combination with Rituximab Versus Standard Immunochemotherapy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - The COASTAL Study
- Follicular Lymphoma, Marginal zone lymphoma
- Hanaya Miyoko
- 2023-05-15
Completed
- A phase I clinical study of KSP-0243
- Healthy Condition
- Shimizu Yoshitaka
- 2021-01-20
Completed
- A Phase I Dose Escalation and Food Effect Study of Isotretinoin
- Severe acne vulgaris
- Toida Tsuneyuki
- 2022-11-25
Completed
- A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7442 in Healthy Japanese Participants
- COVID-19
- Hibi Kazushige
- 2021-03-10
Completed
- A Phase I Single Ascending Dose Study of RO7126209 in Healthy Japanese Subjects
- Alzheimer's disease
- Nanki Toshihiro
- 2021-05-17
Completed
- A PHASE I SINGLE CENTER, OPEN-LABEL, COMBINATION STUDY OF RM-1929 AND PHOTOIMMUNOTHERAPY IN PATIENTS WITH RECURRENT SQUAMOUS CELL HEAD AND NECK CANCER
- Squamous Cell Carcinoma of Head and Neck
- Arron Sarah
- 2020-09-30